Uzbekistan Digital Health Platform - Integrations
0.1.0 - ci-build
Uzbekistan Digital Health Platform - Integrations
0.1.0 - ci-build
Uzbekistan Digital Health Platform - Integrations - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Draft as of 2026-07-13 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="dhis-observation-component-code-cs"/>
<language value="en"/>
<text>
<status value="generated"/>
<div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: CodeSystem dhis-observation-component-code-cs</b></p><a name="dhis-observation-component-code-cs"> </a><a name="hcdhis-observation-component-code-cs"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: uz</p></div><p>This case-sensitive code system <code>https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs</code> defines the following codes in a Is-A hierarchy:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">tub004-0001<a name="dhis-observation-component-code-cs-tub004-0001"> </a></td><td>INH ↑ MIK natijasi</td></tr><tr><td style="white-space:nowrap">tub004-0002<a name="dhis-observation-component-code-cs-tub004-0002"> </a></td><td>INH ↓ MIK / ETH natijasi</td></tr><tr><td style="white-space:nowrap">tub004-0003<a name="dhis-observation-component-code-cs-tub004-0003"> </a></td><td>FQL ↑ MIK natijasi</td></tr><tr><td style="white-space:nowrap">tub004-0004<a name="dhis-observation-component-code-cs-tub004-0004"> </a></td><td>FQL ↓ MIK natijasi</td></tr><tr><td style="white-space:nowrap">tub004-0005<a name="dhis-observation-component-code-cs-tub004-0005"> </a></td><td>AMK/KAN/CAP natijasi</td></tr><tr><td style="white-space:nowrap">tub004-0006<a name="dhis-observation-component-code-cs-tub004-0006"> </a></td><td>AMK/KAN natijasi</td></tr><tr><td style="white-space:nowrap">tub004-0007<a name="dhis-observation-component-code-cs-tub004-0007"> </a></td><td>Rifampitsin (1,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0008<a name="dhis-observation-component-code-cs-tub004-0008"> </a></td><td>Izoniazid (0,1 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0009<a name="dhis-observation-component-code-cs-tub004-0009"> </a></td><td>Etambutol (5,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0010<a name="dhis-observation-component-code-cs-tub004-0010"> </a></td><td>Pirazinamid (100 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0011<a name="dhis-observation-component-code-cs-tub004-0011"> </a></td><td>Levofloksatsin (2,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0012<a name="dhis-observation-component-code-cs-tub004-0012"> </a></td><td>Moksifloksatsin (1,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0013<a name="dhis-observation-component-code-cs-tub004-0013"> </a></td><td>Moksifloksatsin (0,25 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0014<a name="dhis-observation-component-code-cs-tub004-0014"> </a></td><td>Gatifloksatsin (0,25 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0015<a name="dhis-observation-component-code-cs-tub004-0015"> </a></td><td>Amikatsin (1,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0016<a name="dhis-observation-component-code-cs-tub004-0016"> </a></td><td>Protionamid (2,5 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0017<a name="dhis-observation-component-code-cs-tub004-0017"> </a></td><td>Linezolid (1,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0018<a name="dhis-observation-component-code-cs-tub004-0018"> </a></td><td>Klofazimin (1,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0019<a name="dhis-observation-component-code-cs-tub004-0019"> </a></td><td>Bedaquilin (1,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0020<a name="dhis-observation-component-code-cs-tub004-0020"> </a></td><td>Delamanid (0,06 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0021<a name="dhis-observation-component-code-cs-tub004-0021"> </a></td><td>Pretomanid (1,0 mg/ml)</td></tr><tr><td style="white-space:nowrap">tub004-0022<a name="dhis-observation-component-code-cs-tub004-0022"> </a></td><td>Rifampcin</td></tr><tr><td style="white-space:nowrap">tub004-0023<a name="dhis-observation-component-code-cs-tub004-0023"> </a></td><td>Isoniazid ↑MIC</td></tr><tr><td style="white-space:nowrap">tub004-0024<a name="dhis-observation-component-code-cs-tub004-0024"> </a></td><td>Isoniazid ↓MIC</td></tr><tr><td style="white-space:nowrap">tub004-0025<a name="dhis-observation-component-code-cs-tub004-0025"> </a></td><td>Ethionamide-Prothionamide</td></tr><tr><td style="white-space:nowrap">tub004-0026<a name="dhis-observation-component-code-cs-tub004-0026"> </a></td><td>Moxifloxacin ↑MIC</td></tr><tr><td style="white-space:nowrap">tub004-0027<a name="dhis-observation-component-code-cs-tub004-0027"> </a></td><td>Moxifloxacin ↓MIC</td></tr><tr><td style="white-space:nowrap">tub004-0028<a name="dhis-observation-component-code-cs-tub004-0028"> </a></td><td>Levofloxacin</td></tr><tr><td style="white-space:nowrap">tub004-0029<a name="dhis-observation-component-code-cs-tub004-0029"> </a></td><td>Amikacin</td></tr><tr><td style="white-space:nowrap">tub004-0030<a name="dhis-observation-component-code-cs-tub004-0030"> </a></td><td>Kanamycin</td></tr><tr><td style="white-space:nowrap">tub004-0031<a name="dhis-observation-component-code-cs-tub004-0031"> </a></td><td>CM/AS izolyatini identifikatsiya qilish</td></tr><tr><td style="white-space:nowrap">tub004-0032<a name="dhis-observation-component-code-cs-tub004-0032"> </a></td><td>Gradatsiya</td></tr><tr><td style="white-space:nowrap">tub004-0033<a name="dhis-observation-component-code-cs-tub004-0033"> </a></td><td>Kultura identifikatsiyasi</td></tr><tr><td style="white-space:nowrap">tub004-0034<a name="dhis-observation-component-code-cs-tub004-0034"> </a></td><td>M. tuberculosis complex aniqlash natijasi</td></tr><tr><td style="white-space:nowrap">tub004-0035<a name="dhis-observation-component-code-cs-tub004-0035"> </a></td><td>CM/AS izolyatini identifikatsiya qilish</td></tr><tr><td style="white-space:nowrap">tub004-0036<a name="dhis-observation-component-code-cs-tub004-0036"> </a></td><td>ARVT (Antiretrovirusli terapiya)</td></tr><tr><td style="white-space:nowrap">tub004-0037<a name="dhis-observation-component-code-cs-tub004-0037"> </a></td><td>KTR boshlandi</td></tr></table><p><b>Additional Language Displays</b></p><table class="codes"><tr><td><b>Code</b></td><td><b>English (English, en)</b></td><td><b>Русский (Russian, ru)</b></td></tr><tr><td>tub004-0001</td><td>INH high MIC result</td><td>Результат INH ↑МИК</td></tr><tr><td>tub004-0002</td><td>INH low MIC / ETH result</td><td>Результат INH ↓МИК / ETH</td></tr><tr><td>tub004-0003</td><td>FQL high MIC result</td><td>Результат FQL ↑МИК</td></tr><tr><td>tub004-0004</td><td>FQL low MIC result</td><td>Результат FQL ↓МИК</td></tr><tr><td>tub004-0005</td><td>AMK/KAN/CAP result</td><td>Результат AMK/KAN/CAP</td></tr><tr><td>tub004-0006</td><td>AMK/KAN result</td><td>Результат AMK/KAN</td></tr><tr><td>tub004-0007</td><td>Rifampicin (1.0 mg/mL)</td><td>Рифампицин (1,0 мг/мл)</td></tr><tr><td>tub004-0008</td><td>Isoniazid (0.1 mg/mL)</td><td>Изониазид (0,1 мг/мл)</td></tr><tr><td>tub004-0009</td><td>Ethambutol (5.0 mg/mL)</td><td>Этамбутол (5,0 мг/мл)</td></tr><tr><td>tub004-0010</td><td>Pyrazinamide (100 mg/mL)</td><td>Пиразинамид (100 мг/мл)</td></tr><tr><td>tub004-0011</td><td>Levofloxacin (2.0 mg/mL)</td><td>Левофлоксацин (2,0 мг/мл)</td></tr><tr><td>tub004-0012</td><td>Moxifloxacin (1.0 mg/mL)</td><td>Моксифлоксацин (1,0 мг/мл)</td></tr><tr><td>tub004-0013</td><td>Moxifloxacin (0.25 mg/mL)</td><td>Моксифлоксацин (0,25 мг/мл)</td></tr><tr><td>tub004-0014</td><td>Gatifloxacin (0.25 mg/mL)</td><td>Гатифлоксацин (0,25 мг/мл)</td></tr><tr><td>tub004-0015</td><td>Amikacin (1.0 mg/mL)</td><td>Амикацин (1,0 мг/мл)</td></tr><tr><td>tub004-0016</td><td>Prothionamide (2.5 mg/mL)</td><td>Протионамид (2,5 мг/мл)</td></tr><tr><td>tub004-0017</td><td>Linezolid (1.0 mg/mL)</td><td>Линезолид (1,0 мг/мл)</td></tr><tr><td>tub004-0018</td><td>Clofazimine (1.0 mg/mL)</td><td>Клофазимин (1,0 мг/мл)</td></tr><tr><td>tub004-0019</td><td>Bedaquiline (1.0 mg/mL)</td><td>Бедаквилин (1,0 мг/мл)</td></tr><tr><td>tub004-0020</td><td>Delamanid (0.06 mg/mL)</td><td>Деламанид (0,06 мг/мл)</td></tr><tr><td>tub004-0021</td><td>Pretomanid (1.0 mg/mL)</td><td>Претоманид (1,0 мг/мл)</td></tr><tr><td>tub004-0022</td><td>Rifampcin</td><td>Рифампциин</td></tr><tr><td>tub004-0023</td><td>Isoniazid ↑MIC</td><td>Изониazid ↑МИK</td></tr><tr><td>tub004-0024</td><td>Isoniazid ↓MIC</td><td>Изониazid ↓МИK</td></tr><tr><td>tub004-0025</td><td>Ethionamide-Prothionamide</td><td>Этионамид-Протионамид</td></tr><tr><td>tub004-0026</td><td>Moxifloxacin ↑MIC</td><td>Моксифлоксацин ↑МИК</td></tr><tr><td>tub004-0027</td><td>Moxifloxacin ↓MIC</td><td>Моксифлоксацин ↓МИК</td></tr><tr><td>tub004-0028</td><td>Levofloxacin</td><td>Левофлоксацин</td></tr><tr><td>tub004-0029</td><td>Amikacin</td><td>Амикацин</td></tr><tr><td>tub004-0030</td><td>Kanamycin</td><td>Канамицин</td></tr><tr><td>tub004-0031</td><td>CM/AS isolate identification</td><td>Идентификация изолята CM/AS</td></tr><tr><td>tub004-0032</td><td>Grading</td><td>Градация</td></tr><tr><td>tub004-0033</td><td>Culture identification</td><td>Идентификация культуры</td></tr><tr><td>tub004-0034</td><td>Result of M. tuberculosis complex detection</td><td>Результат определения M. tuberculosis complex</td></tr><tr><td>tub004-0035</td><td>CM/AS isolate identification</td><td>Идентификация изолята CM/AS</td></tr><tr><td>tub004-0036</td><td>ART (Antiretroviral Therapy)</td><td>АРВТ (антиретровирусная терапия)</td></tr><tr><td>tub004-0037</td><td>KTR begin</td><td>КТР начато</td></tr></table></div>
</text>
<url
value="https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs"/>
<version value="0.1.0"/>
<name value="DHISObservationComponentCodeCS"/>
<title value="DHIS Observation Component Code CodeSystem"/>
<status value="draft"/>
<experimental value="true"/>
<date value="2026-07-13T16:58:44+05:00"/>
<publisher value="Uzinfocom LLC"/>
<contact>
<name value="Uzinfocom LLC"/>
<telecom>
<system value="url"/>
<value value="https://uzinfocom.uz"/>
</telecom>
<telecom>
<system value="email"/>
<value value="info@uzinfocom.uz"/>
</telecom>
</contact>
<description
value="Local code system of tuberculosis observation component codes, including drug-susceptibility-test agents, used by the DHIS information system with Russian and English designations. The DHIS Observation Component Code to LOINC ConceptMap records the LOINC [Susceptibility] concept for the drug agents; in resources use the LOINC code directly wherever an exact match exists (see the DHIS Observation Component Code ValueSet), keeping a local code only where no exact LOINC match exists."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="UZ"/>
<display value="Uzbekistan"/>
</coding>
</jurisdiction>
<caseSensitive value="true"/>
<hierarchyMeaning value="is-a"/>
<content value="complete"/>
<count value="37"/>
<concept>
<code value="tub004-0001"/>
<display value="INH ↑ MIK natijasi"/>
<designation>
<language value="ru"/>
<value value="Результат INH ↑МИК"/>
</designation>
<designation>
<language value="en"/>
<value value="INH high MIC result"/>
</designation>
</concept>
<concept>
<code value="tub004-0002"/>
<display value="INH ↓ MIK / ETH natijasi"/>
<designation>
<language value="ru"/>
<value value="Результат INH ↓МИК / ETH"/>
</designation>
<designation>
<language value="en"/>
<value value="INH low MIC / ETH result"/>
</designation>
</concept>
<concept>
<code value="tub004-0003"/>
<display value="FQL ↑ MIK natijasi"/>
<designation>
<language value="ru"/>
<value value="Результат FQL ↑МИК"/>
</designation>
<designation>
<language value="en"/>
<value value="FQL high MIC result"/>
</designation>
</concept>
<concept>
<code value="tub004-0004"/>
<display value="FQL ↓ MIK natijasi"/>
<designation>
<language value="ru"/>
<value value="Результат FQL ↓МИК"/>
</designation>
<designation>
<language value="en"/>
<value value="FQL low MIC result"/>
</designation>
</concept>
<concept>
<code value="tub004-0005"/>
<display value="AMK/KAN/CAP natijasi"/>
<designation>
<language value="ru"/>
<value value="Результат AMK/KAN/CAP"/>
</designation>
<designation>
<language value="en"/>
<value value="AMK/KAN/CAP result"/>
</designation>
</concept>
<concept>
<code value="tub004-0006"/>
<display value="AMK/KAN natijasi"/>
<designation>
<language value="ru"/>
<value value="Результат AMK/KAN"/>
</designation>
<designation>
<language value="en"/>
<value value="AMK/KAN result"/>
</designation>
</concept>
<concept>
<code value="tub004-0007"/>
<display value="Rifampitsin (1,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Рифампицин (1,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Rifampicin (1.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0008"/>
<display value="Izoniazid (0,1 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Изониазид (0,1 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Isoniazid (0.1 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0009"/>
<display value="Etambutol (5,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Этамбутол (5,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Ethambutol (5.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0010"/>
<display value="Pirazinamid (100 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Пиразинамид (100 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Pyrazinamide (100 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0011"/>
<display value="Levofloksatsin (2,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Левофлоксацин (2,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Levofloxacin (2.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0012"/>
<display value="Moksifloksatsin (1,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Моксифлоксацин (1,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Moxifloxacin (1.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0013"/>
<display value="Moksifloksatsin (0,25 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Моксифлоксацин (0,25 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Moxifloxacin (0.25 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0014"/>
<display value="Gatifloksatsin (0,25 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Гатифлоксацин (0,25 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Gatifloxacin (0.25 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0015"/>
<display value="Amikatsin (1,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Амикацин (1,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Amikacin (1.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0016"/>
<display value="Protionamid (2,5 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Протионамид (2,5 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Prothionamide (2.5 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0017"/>
<display value="Linezolid (1,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Линезолид (1,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Linezolid (1.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0018"/>
<display value="Klofazimin (1,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Клофазимин (1,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Clofazimine (1.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0019"/>
<display value="Bedaquilin (1,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Бедаквилин (1,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Bedaquiline (1.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0020"/>
<display value="Delamanid (0,06 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Деламанид (0,06 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Delamanid (0.06 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0021"/>
<display value="Pretomanid (1,0 mg/ml)"/>
<designation>
<language value="ru"/>
<value value="Претоманид (1,0 мг/мл)"/>
</designation>
<designation>
<language value="en"/>
<value value="Pretomanid (1.0 mg/mL)"/>
</designation>
</concept>
<concept>
<code value="tub004-0022"/>
<display value="Rifampcin"/>
<designation>
<language value="ru"/>
<value value="Рифампциин"/>
</designation>
<designation>
<language value="en"/>
<value value="Rifampcin"/>
</designation>
</concept>
<concept>
<code value="tub004-0023"/>
<display value="Isoniazid ↑MIC"/>
<designation>
<language value="ru"/>
<value value="Изониazid ↑МИK"/>
</designation>
<designation>
<language value="en"/>
<value value="Isoniazid ↑MIC"/>
</designation>
</concept>
<concept>
<code value="tub004-0024"/>
<display value="Isoniazid ↓MIC"/>
<designation>
<language value="ru"/>
<value value="Изониazid ↓МИK"/>
</designation>
<designation>
<language value="en"/>
<value value="Isoniazid ↓MIC"/>
</designation>
</concept>
<concept>
<code value="tub004-0025"/>
<display value="Ethionamide-Prothionamide"/>
<designation>
<language value="ru"/>
<value value="Этионамид-Протионамид"/>
</designation>
<designation>
<language value="en"/>
<value value="Ethionamide-Prothionamide"/>
</designation>
</concept>
<concept>
<code value="tub004-0026"/>
<display value="Moxifloxacin ↑MIC"/>
<designation>
<language value="ru"/>
<value value="Моксифлоксацин ↑МИК"/>
</designation>
<designation>
<language value="en"/>
<value value="Moxifloxacin ↑MIC"/>
</designation>
</concept>
<concept>
<code value="tub004-0027"/>
<display value="Moxifloxacin ↓MIC"/>
<designation>
<language value="ru"/>
<value value="Моксифлоксацин ↓МИК"/>
</designation>
<designation>
<language value="en"/>
<value value="Moxifloxacin ↓MIC"/>
</designation>
</concept>
<concept>
<code value="tub004-0028"/>
<display value="Levofloxacin"/>
<designation>
<language value="ru"/>
<value value="Левофлоксацин"/>
</designation>
<designation>
<language value="en"/>
<value value="Levofloxacin"/>
</designation>
</concept>
<concept>
<code value="tub004-0029"/>
<display value="Amikacin"/>
<designation>
<language value="ru"/>
<value value="Амикацин"/>
</designation>
<designation>
<language value="en"/>
<value value="Amikacin"/>
</designation>
</concept>
<concept>
<code value="tub004-0030"/>
<display value="Kanamycin"/>
<designation>
<language value="ru"/>
<value value="Канамицин"/>
</designation>
<designation>
<language value="en"/>
<value value="Kanamycin"/>
</designation>
</concept>
<concept>
<code value="tub004-0031"/>
<display value="CM/AS izolyatini identifikatsiya qilish"/>
<designation>
<language value="ru"/>
<value value="Идентификация изолята CM/AS"/>
</designation>
<designation>
<language value="en"/>
<value value="CM/AS isolate identification"/>
</designation>
</concept>
<concept>
<code value="tub004-0032"/>
<display value="Gradatsiya"/>
<designation>
<language value="ru"/>
<value value="Градация"/>
</designation>
<designation>
<language value="en"/>
<value value="Grading"/>
</designation>
</concept>
<concept>
<code value="tub004-0033"/>
<display value="Kultura identifikatsiyasi"/>
<designation>
<language value="ru"/>
<value value="Идентификация культуры"/>
</designation>
<designation>
<language value="en"/>
<value value="Culture identification"/>
</designation>
</concept>
<concept>
<code value="tub004-0034"/>
<display value="M. tuberculosis complex aniqlash natijasi"/>
<designation>
<language value="ru"/>
<value value="Результат определения M. tuberculosis complex"/>
</designation>
<designation>
<language value="en"/>
<value value="Result of M. tuberculosis complex detection"/>
</designation>
</concept>
<concept>
<code value="tub004-0035"/>
<display value="CM/AS izolyatini identifikatsiya qilish"/>
<designation>
<language value="ru"/>
<value value="Идентификация изолята CM/AS"/>
</designation>
<designation>
<language value="en"/>
<value value="CM/AS isolate identification"/>
</designation>
</concept>
<concept>
<code value="tub004-0036"/>
<display value="ARVT (Antiretrovirusli terapiya)"/>
<designation>
<language value="ru"/>
<value value="АРВТ (антиретровирусная терапия)"/>
</designation>
<designation>
<language value="en"/>
<value value="ART (Antiretroviral Therapy)"/>
</designation>
</concept>
<concept>
<code value="tub004-0037"/>
<display value="KTR boshlandi"/>
<designation>
<language value="ru"/>
<value value="КТР начато"/>
</designation>
<designation>
<language value="en"/>
<value value="KTR begin"/>
</designation>
</concept>
</CodeSystem>